Oncology PracticeModel reveals genes associated with prognosis in ER+, HER2– breast cancerFebruary 12, 2020Breast Cancer
Oncology PracticeFDA: Cell phones still look safeFebruary 11, 2020Mixed TopicsCNS/Brain CancerBreast CancerLung CancerLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationGynecologic Cancer
Oncology PracticeAbbreviated MRI equals standard protocol for high-risk breast cancer screensFebruary 9, 2020Preventive CareBreast Cancer
Oncology PracticeData emerging to support personalized nutrition in oncologyFebruary 8, 2020Breast CancerCNS/Brain CancerPreventive Care
New tools could help predict complication risks in lung and breast cancerFebruary 6, 2020Lung CancerBreast CancerLung Cancer
Oncology PracticeGlobal project reveals cancer’s genomic playbookFebruary 5, 2020Mixed TopicsCNS/Brain CancerBreast CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHead & Neck/Thyroid CancersGynecologic Cancer
Oncology PracticeHigh-dose chemo offers survival benefit only for highest-risk breast cancerJanuary 30, 2020Breast Cancer
Oncology PracticeScore predicts locoregional recurrence of breast cancerJanuary 13, 2020Breast Cancer
Oncology PracticeInsurance coverage mediates racial disparities in breast cancerJanuary 11, 2020Breast CancerPractice Management
Oncology PracticeSensitivity of ctDNA equivalent to that of tumor tissue sequencingDecember 20, 2019Breast Cancer
Oncology PracticeNeoadjuvant cisplatin fails to beat standard AC in HER2-negative breast cancerDecember 20, 2019Breast Cancer
